We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Quest Diagnostics Inc | NYSE:DGX | NYSE | Common Stock |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 136.34 | 0 | 11:19:30 |
Large accelerated filer
x
|
|
Accelerated filer
o
|
Non-accelerated filer
o
(Do not check if a smaller reporting company)
|
|
Smaller reporting company
o
|
Title of Securities to be Registered
|
Amount to be Registered (1)
|
Proposed Maximum Offering Price Per Share (2)
|
Proposed Maximum Aggregate Offering Price (2)
|
Amount of Registration Fee
|
Common Stock, Par Value $0.01
|
4,000,000 Shares
|
$83.36
|
$333,440,000
|
$38,646
|
(1)
|
Represents the number of shares of Common Stock authorized for issuance pursuant to the Quest Diagnostics Incorporated Amended and Restated Employee Stock Purchase Plan (the “Plan”). Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the “Securities Act”), this registration statement on Form S-8 also covers an indeterminate amount of additional shares of Common Stock that may be offered or delivered under the Plan to prevent dilution resulting from any stock dividend, stock split, recapitalization or other similar transaction. No additional registration fee is included for these shares.
|
(2)
|
Estimated pursuant to Rules 457(c) and 457(h) under the Securities Act solely for the purpose of calculating the registration fee based upon the average of the high and low prices reported for the shares of Common Stock on the New York Stock Exchange on October 19, 2016.
|
Quest Diagnostics Incorporated
|
|
By:
/s/ Stephen H. Rusckowski
Stephen H. Rusckowski
|
President and Chief Executive Officer
|
Signatures
|
Capacity
|
/s/ Stephen H. Rusckowski
Stephen H. Rusckowski
|
President and Chief Executive Officer and Director
|
/s/ Mark J. Guinan
Mark J. Guinan
|
Senior Vice President and Chief Financial Officer
|
/s/ Robert A. Klug
Robert A. Klug
|
Vice President, Corporate Controller and Chief Accounting Officer
|
/s/ Jenne K. Britell, Ph.D.
Jenne K. Britell, Ph.D.
|
Director
|
/s/ Vicky B. Gregg
Vicky B. Gregg
|
Director
|
/s/ Jeffrey M. Leiden, M.D., Ph.D.
Jeffrey M. Leiden, M.D., Ph.D.
|
Director
|
/s/ Timothy L. Main
Timothy L. Main
|
Director
|
/s/ Gary M. Pfeiffer
Gary M. Pfeiffer
|
Director
|
/s/ Timothy M. Ring
Timothy M. Ring
|
Director
|
/s/ Daniel C. Stanzione, Ph.D.
Daniel C. Stanzione, Ph.D.
|
Chairman of the Board
|
/s/ Gail R. Wilensky, Ph.D.
Gail R. Wilensky, Ph.D.
|
Director
|
/s/ John B. Ziegler
John B. Ziegler
|
Director
|
4.1
|
Quest Diagnostics Incorporated Amended and Restated Employee Stock Purchase Plan (filed as an Exhibit to the Corporation's Quarterly Report on Form 10-Q for the quarter ended June 30, 2016 (Date of Report: July 25, 2016) and incorporated herein by reference (Commission File Number 001-12215)
|
4.2
|
Restated Certificate of Incorporation (filed as an Exhibit to the Corporation's current report on Form 8-K (Date of Report: May 20, 2014) and incorporated herein by reference) (Commission File Number 001-12215)
|
4.3
|
Amended and Restated By-Laws of the Company (filed as an Exhibit to the Corporation's current report on Form 8-K (Date of Report: February 25, 2016) and incorporated herein by reference) (Commission File Number 001-12215)
|
1 Year Quest Diagnostics Chart |
1 Month Quest Diagnostics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions